Pharma Tech

US targets Chinese biotech investment, but licensing deals remain exempt

Oct 23, 2026, 3:17 PM

Read Full Article → US targets Chinese biotech investment, but licensing deals remain exempt

Translate article text

Choose a language and wait for the translated text.

Numerous types of equity deals involving Chinese biotech, including the popular NewCo model, will be impacted by the proposed rule.